Jaguar Health, Inc.
JAGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.5% | 34.6% | -36.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64.6% | 82.3% | 76.7% | 84.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -294.6% | -250.1% | -400.9% | -448.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -308.2% | -349.3% | -472.6% | -282.7% |
| EPS Diluted | -6.28 | -10.26 | -16.7 | -33.68 |
| % Growth | 38.8% | 38.6% | 50.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |